In stock
Guaranteed refund or reship if you haven't received your order
Secure and encrypted payment processing
We ship to over 40 countries including the USA, UK, Europe, Australia and Japan

The effect of the drug is due to the action of its active components.

Levodropropisinum is an antitussive agent of mainly peripheral action, which helps to reduce the frequency and intensity of cough, has a bronchodilator effect. Unlike other antitussive drugs, tolerance or dependence does not occur in levodropropizine. Its effect on the central nervous system is much less than in dropropisin. The effectiveness of levodropropisine is due to inhibition of the sensitivity of the receptors of the bronchial tree. The effectiveness of the drug has been proven in clinical studies and is more than 90%. Levodropropisin acts at the level of nerve receptors by inhibiting the conduction of a nerve impulse along C-fibers. Suppresses the release of neuropeptides, such as substance P and others, as well as histamine, due to which a significant bronchodilator effect is achieved.


Symptomatic treatment of dry unproductive cough with pharyngitis, laryngitis, tracheitis, tracheobronchitis, flu, bronchial asthma, emphysema, chronic obstructive bronchitis, with allergic and infectious inflammatory diseases of the respiratory tract, as well as with lung tumors.


Hypersensitivity to levodropropisine or other components of the drug, the presence or excessive secretion of sputum, decreased mucociliary function (Cartagener syndrome, ciliary dyskinesia), severe liver and kidney dysfunction.

Dosage and administration

The drug is intended for oral administration.

The drug should be used from 1:00 before or 2:00 after eating.

Adults and children over 12 years of age should be prescribed 10 ml (equivalent to 60 mg of levodropropisine) 3 times a day at intervals of at least 6:00.

For children aged 2 to 12 years, apply a dose of 1 mg / kg body weight 3 times a day, the total daily dose is 3 mg / kg body weight. For convenience, you can apply the following approximate doses:

  • for children with a body weight of 10-20 kg, apply 3 ml up to 3 times a day
  • for children with a body weight of 20-30 kg, apply 5 ml up to 3 times a day.

The duration of treatment is determined by the doctor and should not exceed 7 days. If symptoms persist within 4-5 days, treatment should be discontinued and a doctor should be consulted.


The drug is contraindicated in children under the age of 2 years.


Symptoms: tachycardia, drowsiness, impaired consciousness, nausea, vomiting, or increased manifestations of other adverse reactions.

Treatment: there is no specific antidote. It is necessary to rinse the stomach, prescribe sorbents and parenteral administration of plasma solutions.


active substance: levodropropisin;

5 ml of syrup contain 30 mg of levodropropisin

Excipients: sodium saccharin, sodium methyl parahydroxybenzoate (E 219), sodium propyl parahydroxybenzoate (E 217), sodium carboxymethyl cellulose; sorbitol solution that does not crystallize (E 420) citric acid monohydrate, ponso 4R (E 124), orange flavor, RSV fruit mixture, propylene glycol, purified water.

Storage conditions

Store at a temperature not exceeding 30 ° C.

Keep out of the reach of children.

Shelf life is 2 years.

Tags: Rapitus® [Levodropropizine]